within Pharmacolibrary.Drugs.ATC.C;

model C05BB56
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C05BB56</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Glucose, combinations (ATC code C05BB56), are topical preparations containing glucose along with other agents, primarily used for their osmotic and dehydrating properties in the treatment of hemorrhoids and varicose veins. Such combinations may include sclerosant therapy where glucose solutions are used to induce sclerosis in the affected veins. This preparation is approved for local, topical use and not for systemic treatment of metabolic disorders.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for topical/locally administered glucose combinations in adult patients. No direct systemic pharmacokinetic data available, as these products are intended for topical/local use and not meant for systemic exposure measurement.</p><h4>References</h4><ol><li><p>Machida, Y (1993). [Development of topical drug delivery systems utilizing polymeric materials]. <i>Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan</i> 113(5) 356–368. DOI:<a href=\"https://doi.org/10.1248/yakushi1947.113.5_356\">10.1248/yakushi1947.113.5_356</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8336278/\">https://pubmed.ncbi.nlm.nih.gov/8336278</a></p></li><li><p>Morgan, RV (1995). Delivery of systemic regular insulin via the ocular route in cats. <i>Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics</i> 11(4) 565–573. DOI:<a href=\"https://doi.org/10.1089/jop.1995.11.565\">10.1089/jop.1995.11.565</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8574820/\">https://pubmed.ncbi.nlm.nih.gov/8574820</a></p></li><li><p>Zakaria, el R, et al., &amp; Fituri, OM (2014). Hyperosmolality-mediated peritoneal microvascular vasodilation is linked to aquaporin function. <i>Advances in peritoneal dialysis. Conference on Peritoneal Dialysis</i> 30 63–74. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25338424/\">https://pubmed.ncbi.nlm.nih.gov/25338424</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C05BB56;
